(E)-4-[3-[2-[[4-(2,4-dichlorophenyl)-1,3-thiazol-2-yl]amino]-2-oxoethyl]sulfanylanilino]-4-oxobut-2-enoic acid

C21H15Cl2N3O4S2 — CID 18895347

IUPAC(E)-4-[3-[2-[[4-(2,4-dichlorophenyl)-1,3-thiazol-2-yl]amino]-2-oxoethyl]sulfanylanilino]-4-oxobut-2-enoic acid
SMILESO=C(O)/C=C/C(=O)Nc1cccc(SCC(=O)Nc2nc(-c3ccc(Cl)cc3Cl)cs2)c1
InChIInChI=1S/C21H15Cl2N3O4S2/c22-12-4-5-15(16(23)8-12)17-10-32-21(25-17)26-19(28)11-31-14-3-1-2-13(9-14)24-18(27)6-7-20(29)30/h1-10H,11H2,(H,24,27)(H,29,30)(H,25,26,28)/b7-6+
InChIKeyRCCKPWJHXLGZQI-VOTSOKGWSA-N
MW508.41 g/mol
LogP5.43
Rot. Bonds8

About (E)-4-[3-[2-[[4-(2,4-dichlorophenyl)-1,3-thiazol-2-yl]amino]-2-oxoethyl]sulfanylanilino]-4-oxobut-2-enoic acid

(E)-4-[3-[2-[[4-(2,4-dichlorophenyl)-1,3-thiazol-2-yl]amino]-2-oxoethyl]sulfanylanilino]-4-oxobut-2-enoic acid (PubChem CID 18895347) has the molecular formula C21H15Cl2N3O4S2 and a molecular weight of 508.41 g/mol. Its IUPAC name is (E)-4-[3-[2-[[4-(2,4-dichlorophenyl)-1,3-thiazol-2-yl]amino]-2-oxoethyl]sulfanylanilino]-4-oxobut-2-enoic acid.

Molecular Properties

Compound Name(E)-4-[3-[2-[[4-(2,4-dichlorophenyl)-1,3-thiazol-2-yl]amino]-2-oxoethyl]sulfanylanilino]-4-oxobut-2-enoic acid
PubChem CID18895347
Molecular FormulaC21H15Cl2N3O4S2
Molecular Weight508.41 g/mol
Exact Mass506.99
IUPAC Name(E)-4-[3-[2-[[4-(2,4-dichlorophenyl)-1,3-thiazol-2-yl]amino]-2-oxoethyl]sulfanylanilino]-4-oxobut-2-enoic acid
SMILESO=C(O)/C=C/C(=O)Nc1cccc(SCC(=O)Nc2nc(-c3ccc(Cl)cc3Cl)cs2)c1
InChIInChI=1S/C21H15Cl2N3O4S2/c22-12-4-5-15(16(23)8-12)17-10-32-21(25-17)26-19(28)11-31-14-3-1-2-13(9-14)24-18(27)6-7-20(29)30/h1-10H,11H2,(H,24,27)(H,29,30)(H,25,26,28)/b7-6+
InChIKeyRCCKPWJHXLGZQI-VOTSOKGWSA-N
XLogP5.43
TPSA108.39 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms32
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500508.41
LogP ≤ 55.43
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (E)-4-[3-[2-[[4-(2,4-dichlorophenyl)-1,3-thiazol-2-yl]amino]-2-oxoethyl]sulfanylanilino]-4-oxobut-2-enoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (E)-4-[3-[2-[[4-(2,4-dichlorophenyl)-1,3-thiazol-2-yl]amino]-2-oxoethyl]sulfanylanilino]-4-oxobut-2-enoic acid?
The IUPAC name of (E)-4-[3-[2-[[4-(2,4-dichlorophenyl)-1,3-thiazol-2-yl]amino]-2-oxoethyl]sulfanylanilino]-4-oxobut-2-enoic acid (CID 18895347) is (E)-4-[3-[2-[[4-(2,4-dichlorophenyl)-1,3-thiazol-2-yl]amino]-2-oxoethyl]sulfanylanilino]-4-oxobut-2-enoic acid.
What is the SMILES notation for (E)-4-[3-[2-[[4-(2,4-dichlorophenyl)-1,3-thiazol-2-yl]amino]-2-oxoethyl]sulfanylanilino]-4-oxobut-2-enoic acid?
The canonical SMILES for (E)-4-[3-[2-[[4-(2,4-dichlorophenyl)-1,3-thiazol-2-yl]amino]-2-oxoethyl]sulfanylanilino]-4-oxobut-2-enoic acid is O=C(O)/C=C/C(=O)Nc1cccc(SCC(=O)Nc2nc(-c3ccc(Cl)cc3Cl)cs2)c1.
What is the InChIKey of (E)-4-[3-[2-[[4-(2,4-dichlorophenyl)-1,3-thiazol-2-yl]amino]-2-oxoethyl]sulfanylanilino]-4-oxobut-2-enoic acid?
The InChIKey is RCCKPWJHXLGZQI-VOTSOKGWSA-N. The full InChI is InChI=1S/C21H15Cl2N3O4S2/c22-12-4-5-15(16(23)8-12)17-10-32-21(25-17)26-19(28)11-31-14-3-1-2-13(9-14)24-18(27)6-7-20(29)30/h1-10H,11H2,(H,24,27)(H,29,30)(H,25,26,28)/b7-6+.
What are the key properties of (E)-4-[3-[2-[[4-(2,4-dichlorophenyl)-1,3-thiazol-2-yl]amino]-2-oxoethyl]sulfanylanilino]-4-oxobut-2-enoic acid?
(E)-4-[3-[2-[[4-(2,4-dichlorophenyl)-1,3-thiazol-2-yl]amino]-2-oxoethyl]sulfanylanilino]-4-oxobut-2-enoic acid has a molecular weight of 508.41 g/mol, XLogP of 5.43, 8 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-4-[3-[2-[[4-(2,4-dichlorophenyl)-1,3-thiazol-2-yl]amino]-2-oxoethyl]sulfanylanilino]-4-oxobut-2-enoic acid is sourced from PubChem (CID 18895347), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).